Drug companies should take more responsibility for the safety of ingredients sourced overseas, and Congress should make them if they do not, according to the new U.S. drug regulator for import safety. The Food and Drug Administration should also have the power to stop medicines at the border if their manufacturers refused FDA inspections, and the power to order mandatory recalls of unsafe products, said Deborah Autor, the agency’s newly appointed deputy commissioner. “People are shocked when they learn that we do not have mandatory recalls (of drugs),” Autor told Reuters in her first interview since she was named head of global compliance earlier this month.
